Lazard Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
|
|||||
|
2025
Q1 | $1.83M | Buy |
|
|||||
|
2024
Q4 | $228K | Sell |
|
|||||
|
2024
Q3 | $917K | Buy |
|
|||||
|
2024
Q2 | $452K | Buy |
|
|||||
|
2024
Q1 | $339K | Buy |
|
|||||
|
2023
Q4 | $335K | Buy |
|
|||||
|
2023
Q3 | $296K | Buy |
|
|||||
|
2023
Q2 | $209K | Sell |
|
|||||
|
2023
Q1 | $220K | Buy |
|
|||||
|
2022
Q4 | $139K | Sell |
|
|||||
|
2022
Q3 | $178K | Sell |
|
|||||
|
2022
Q2 | $207K | Buy |
|
|||||
|
2022
Q1 | $186K | Sell |
|
|||||
|
2021
Q4 | $176K | Buy |
|
|||||
|
2021
Q3 | $42K | Sell |
|
|||||
|
2021
Q2 | $74K | Buy |
|
|||||
|
2021
Q1 | $1K | Sell |
|
|||||
|
2020
Q4 | $115K | Buy |
|
|||||
|
2020
Q3 | $55K | Sell |
|
|||||
|
2020
Q2 | $95K | Sell |
|
|||||
|
2020
Q1 | $124K | Sell |
|
|||||
|
2019
Q4 | $759K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.83M | Buy |
|